Resources

Type of publications
Regions
Diseases
5052 results found
2024 ∙ Lamichhane, P. Khalid, H. Siviyachan, C. K. Zafar, S. Prasanth, M. Khanal, K. Agrawal, A. Kaur Jhajj, L.
Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Hua, T. Fan, R. Fan, Y. Chen, F.
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Olakunde, B. O. Ifeorah, I. M. Adeyinka, D. A. Olakunde, O. A. Ogundipe, T. Olawepo, J. O. Ezeanolue, E. E.
Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis
Africa Children Newborn Hepatitis B Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Chue, W. X. Lienardi, L. A. Tan, T. Q. W. Kadir, I. A. Lam, J. C. M.
Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis
All age groups COVID-19 Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Zemariam, A. B. Abebe, G. K. Kassa, M. A. Alamaw, A. W. Molla, R. W. Abate, B. B. Tilahun, B. D. Wondie, W. T. Shimelash, R. A. Fentanew, M.
Immunization coverage and its associated factors among children aged 12-23 months in Ethiopia: An umbrella review of systematic review and meta-analysis studies
Africa Ethiopia Children Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Bytyci, J. Ying, Y. Lee, L. Y. W.
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Tian, Z. Chen, Y. Yao, Y. Chen, L. Zhu, X. Shen, Z. Yang, S. Jin, H.
Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Rosso, A. Flacco, M. E. Cioni, G. Tiseo, M. Imperiali, G. Bianconi, A. Fiore, M. Calo, G. L. Orazi, V. Troia, A. Manzoli, L.
Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis
Adults Adolescents Older adults Chikungunya Safety Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Yin, J. Zhang, L. Wang, C. Qin, C. Miao, M.
Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials
Adults Ebola Safety Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Carta, V. Mangeri, L. Tiecco, G. Foca, E. Quiros-Roldan, E. De Francesco, M. A.
Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
Children Adolescents Adults Varicella Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...